TY - JOUR
T1 - Alternate vaccine strain selection in the wake of emerging foot-and-mouth disease virus serotype A antigenic variants in India
AU - Mohapatra, Jajati Keshari
AU - Das, Biswajit
AU - Rout, Manoranjan
AU - Sreenivasa, B. P.
AU - Subramaniam, Saravanan
AU - Sanyal, Aniket
AU - Pattnaik, Bramhadev
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/5/31
Y1 - 2018/5/31
N2 - ‘National foot-and-mouth disease (FMD) control programme’ is being implemented in India and therefore predicting vaccine match is a key surveillance task. Recently, a considerable proportion of field viruses (75.6%) showed antigenic drift from the existing serotype A vaccine strain A IND 40/2000 necessitating search for an alternate strain. Here, antigenic relationship (‘r1’ value) of 87 field viruses with each of the 8 candidate strains was estimated by virus neutralization test. A IND 27/2011 strain emerged to be the one with the widest spectrum of antigenic coverage showing ‘r1’ value of more than 0.3 with 81.6% of field strains. It achieved a reasonably high titre of log10 7.5 TCID50/ml in BHK-21 suspension cell which was accompanied by positive charge gaining substitutions (E82–K and E131–K in VP2) thought to have adaptive significance. However, potency trial remains to be conducted before A IND 27/2011 finds a place in the vaccine formulation.
AB - ‘National foot-and-mouth disease (FMD) control programme’ is being implemented in India and therefore predicting vaccine match is a key surveillance task. Recently, a considerable proportion of field viruses (75.6%) showed antigenic drift from the existing serotype A vaccine strain A IND 40/2000 necessitating search for an alternate strain. Here, antigenic relationship (‘r1’ value) of 87 field viruses with each of the 8 candidate strains was estimated by virus neutralization test. A IND 27/2011 strain emerged to be the one with the widest spectrum of antigenic coverage showing ‘r1’ value of more than 0.3 with 81.6% of field strains. It achieved a reasonably high titre of log10 7.5 TCID50/ml in BHK-21 suspension cell which was accompanied by positive charge gaining substitutions (E82–K and E131–K in VP2) thought to have adaptive significance. However, potency trial remains to be conducted before A IND 27/2011 finds a place in the vaccine formulation.
KW - Alternate vaccine strain selection
KW - FMD virus serotype A
KW - India
KW - VNT
UR - http://www.scopus.com/inward/record.url?scp=85046632856&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2018.04.090
DO - 10.1016/j.vaccine.2018.04.090
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29735325
AN - SCOPUS:85046632856
SN - 0264-410X
VL - 36
SP - 3191
EP - 3194
JO - Vaccine
JF - Vaccine
IS - 23
ER -